NCT07519187

CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms

RecruitingEARLY_PHASE1INTERVENTIONAL

Trial Details

Start: 2026-04-23Est. Completion: 2027-04-01

Enrollment target: 20 participants

Locations

Contact

Multiple MyelomaRelapsed and/or Refractory Multiple Myeloma (RRMM)

Background: Multiple myeloma (MM) is a type of blood cancer that affects a person s immunity. MM returns after treatmen…

Bethesda, United StatesCompleted Jan 1, 2033

Multiple Myeloma

Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marro…

Birmingham, United StatesEst. completion Dec 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.